Oral Contraceptives and Cardiovascular Disease
- 10 September 1981
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 305 (11) , 612-618
- https://doi.org/10.1056/nejm198109103051104
Abstract
WHEN oral contraceptives became generally available during the early 1960s, their use increased rapidly, initially in North America and then elsewhere. By 1965, approximately 15 per cent of all married women 15 to 44 years of age in the United States were taking oral contraceptives; by 1973, this figure had increased to 25 per cent, or about 6.6 million.1 Use in the United States peaked during the mid-1970s but has continued to increase in many other countries.2 Worldwide, it is estimated that about 54 million women were using oral contraceptives by 1977. 2 Evidence suggesting that oral contraceptives might have effects . . .Keywords
This publication has 55 references indexed in Scilit:
- MORTALITY IN ORAL CONTRACEPTIVE USERSThe Lancet, 1981
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- MORTALITY AMONG WOMEN PARTICIPATING IN THE OXFORD/FAMILY PLANNING ASSOCIATION CONTRACEPTIVE STUDYThe Lancet, 1977
- A Long-term follow-up study of women using different methods of contraception— an interim reportJournal of Biosocial Science, 1976
- THROMBOEMBOLISM AND ORAL CONTRACEPTIVERS: AN EPIDEMIOLOGIC CASE-CONTROL STUDY12American Journal of Epidemiology, 1969
- Investigation of Relation between Use of Oral Contraceptives and Thromboembolic Disease. A Further ReportBMJ, 1969
- Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.BMJ, 1968
- Investigation of relation between use of oral contraceptives and thromboembolic disease.BMJ, 1968
- The Final Enovid ReportThe Journal of New Drugs, 1963
- PULMONARY EMBOLISMThe Lancet, 1961